Novadiscovery is a de-risking technology provider specialized in in silico clinical trials supporting biotech and pharma companies, academic research centers and not-for-profit organizations. We help our clients unlock the potential of modeling & simulation to de-risk the R&D of new therapies for the benefit of patients. Based on the Effect Model law, our pioneering approach enables the prediction of the effectiveness of a therapy or the diagnostic value of a biomarker, at the individual and the population level, and compare them with those of competitors. Nova optimizes drug R&D and strengthens healthcare decision-making.